Denmark· DK-28104518809

Copalia HCT

A valsartan, amlodipine and hydrochlorothiazide product containing amlodipinbesilat, hydrochlorthiazid, valsartan, registered in Denmark by Novartis Europharm Limited. The same ATC class is registered in 12 of our 19 countries.

ATC C09DX01

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedCopalia HCTATCC09DX01REGISTER NO.DK-28104518809PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Valsartan, amlodipine and hydrochlorothiazide is registered in 12 of 19 countries.

Countries holding a registration under ATC C09DX01 (valsartan, amlodipine and hydrochlorothiazide), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 9 of them publish a price we can compare per daily dose

Valsartan, amlodipine and hydrochlorothiazide · ATC C09DX01

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
AMLODIPINBESILAT, HYDROCHLORTHIAZID, VALSARTAN
Manufacturer
Novartis Europharm Limited
Country
Denmark (DK)
ATC code
C09DX01
ATC class
Valsartan, amlodipine and hydrochlorothiazide
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104518809

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

48 interactions on record for valsartan, amlodipine and hydrochlorothiazide.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valsartan, amlodipine and hydrochlorothiazide · interactions on record

48 records

48 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b4cac477-b3fa-4a23-b012-e9d545a66f72
GET /v1/drugs/b4cac477-b3fa-4a23-b012-e9d545a66f72?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "10 mg+320 mg+25 mg",
  "auth_role": "RAP",
  "dk_drugid": "28104518809",
  "substance": "AMLODIPINBESILAT, HYDROCHLORTHIAZID, VALSARTAN",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "40121"
}

See everything about valsartan, amlodipine and hydrochlorothiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.